Genmab A/S (CPH:GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
1,992.00
-7.00 (-0.35%)
Aug 10, 2026, 4:59 PM CET

Genmab Revenue

Genmab had revenue of $1.16B USD in the quarter ending June 30, 2026, with 24.86% growth. This brings the company's revenue in the last twelve months to $4.13B, up 28.86% year-over-year. In the year 2025, Genmab had annual revenue of $3.72B with 19.19% growth.

Revenue (ttm)
$4.13B
Revenue Growth
+28.86%
P/S Ratio
4.41
Revenue / Employee
$1.34M
Employees
3,088
Market Cap
119.34B DKK

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.72B599.00M19.19%
Dec 31, 20243.12B731.00M30.59%
Dec 31, 20232.39B302.26M14.48%
Dec 31, 20222.09B800.56M62.19%
Dec 31, 20211.29B-372.56M-22.45%
Dec 31, 20201.66B854.43M106.10%
Dec 31, 2019805.32M340.75M73.35%
Dec 31, 2018464.57M83.44M21.89%
Dec 31, 2017381.13M123.38M47.87%
Dec 31, 2016257.75M92.65M56.12%
Dec 31, 2015165.10M26.80M19.38%
Dec 31, 2014138.30M15.94M13.02%
Dec 31, 2013122.37M36.66M42.78%
Dec 31, 201285.70M24.59M40.23%
Dec 31, 201161.12M-43.27M-41.45%
Dec 31, 2010104.39M-8.77M-7.75%
Dec 31, 2009113.16M-16.25M-12.56%
Dec 31, 2008129.42M25.30M24.29%
Dec 31, 2007104.12M80.20M335.29%
Dec 31, 200623.92M8.33M53.41%
Dec 31, 200515.59M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Novo Nordisk329.43B
Coloplast28.05B
H. Lundbeck25.52B
Demant22.97B
GN Store Nord16.60B
Zealand Pharma9.24B
ALK-Abelló6.56B
Embla Medical6.44B
Revenue Rankings